Procter & Gamble (PG) ended the recent trading session at $146.85, demonstrating a -1.04% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.81%. On the other hand, the Dow registered a gain of 0.27%, and the technology-centric Nasdaq increased by 1.3%.
Prior to today's trading, shares of the world's largest consumer products maker had lost 0.44% lagged the Consumer Staples sector's gain of 3.31% and the S&P 500's gain of 1.13%.
The investment community will be paying close attention to the earnings performance of Procter & Gamble in its upcoming release. The company is slated to reveal its earnings on July 29, 2026. The company's earnings per share (EPS) are projected to be $1.43, reflecting a 3.38% decrease from the same quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $21.43 billion, indicating a 2.58% growth compared to the corresponding quarter of the prior year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $6.9 per share and a revenue of $87.12 billion, signifying shifts of +1.02% and +3.37%, respectively, from the last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Procter & Gamble. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.26% decrease. Right now, Procter & Gamble possesses a Zacks Rank of #4 (Sell).
Looking at its valuation, Procter & Gamble is holding a Forward P/E ratio of 21.01. This indicates a premium in contrast to its industry's Forward P/E of 19.64.
Also, we should mention that PG has a PEG ratio of 6.31. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. Consumer Products - Staples stocks are, on average, holding a PEG ratio of 3.24 based on yesterday's closing prices.
The Consumer Products - Staples industry is part of the Consumer Staples sector. This industry, currently bearing a Zacks Industry Rank of 201, finds itself in the bottom 19% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Procter & Gamble Company (The) (PG): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).